Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and α-phenyl-N-t-butylnitrone: Implications for bioactivation by prostaglandin synthetase
- 1 February 1989
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 97 (2) , 192-202
- https://doi.org/10.1016/0041-008x(89)90325-6
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Effects of the tumor promoter 12-O-tetradecanoylphorbol-13-acetate on phenytoin-induced embryopathy in miceToxicology and Applied Pharmacology, 1989
- Effects of N‐acetylcysteine on fetal development and on phenytoin teratogenicity in miceTeratogenesis, Carcinogenesis, and Mutagenesis, 1988
- Elevated glucocorticoid receptor levels in lymphocytes of children with the fetal hydantoin syndrome (FHS)American Journal of Medical Genetics, 1987
- Pharmacological studies on the potentiation of phenytoin teratogenicity by acetaminophenTeratology, 1986
- GENETIC PREDISPOSITION TO PHENYTOIN-INDUCED BIRTH DEFECTSThe Lancet, 1985
- Predisposition to Phenytoin Hepatotoxicity Assessed in VitroNew England Journal of Medicine, 1981
- Teratogenicity of diphenylhydantoin in the New Zealand white rabbitTeratology, 1980
- Chemical-biological reactions common to teratogenesis and mutagenesisEnvironmental Health Perspectives, 1978
- The fetal hydantoin syndromeThe Journal of Pediatrics, 1975
- Diphenylhydantoin teratogenicity in ratsToxicology and Applied Pharmacology, 1972